CTKI258A2124

Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function


Duke Cancer Institute
315 Trent Drive
Rm 382, Hanes House
Durham, NC 27710
919-681-7264

Novartis Investigative Site
Hannover 30625

Cancer Therapy and Research Center
Health Science Center at San Antonio
7979 Wurzbach Road
San Antonio, TX 78229
210-450-3800

University of California Los Angeles Medical Center
Los Angeles, CA 90095
310-582-6324

Novartis Investigative Site
Gent 9000

Novartis Investigative Site
Hamburg 20246

Novartis Investigative Site
Singapore 119228

Novartis Investigative Site
Rozzano 20089

Novartis Investigative Site
Amsterdam 1066 CX

Novartis Investigative Site
Verona 37126

Novartis Investigative Site
Maastricht 5800

Novartis Investigative Site
Frankfurt 60590

Novartis Investigative Site
Milano 20133